Agilent Increases Cash Dividend to 24.8 Cents per Share
Werte in diesem Artikel
Agilent Technologies, Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 24.8 cents per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 22, 2025, to all shareholders of record as of the close of business on Dec. 31, 2024.
The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
Forward-Looking Statements
This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company’s dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties are detailed in Agilent’s filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2024. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241120074276/en/
Ausgewählte Hebelprodukte auf Agilent Technologies
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Agilent Technologies
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Agilent Technologies Inc.
Analysen zu Agilent Technologies Inc.
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Agilent Technologies Equal Weight | Barclays Capital | |
30.05.2019 | Agilent Technologies Peer Perform | Wolfe Research | |
25.02.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
03.01.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
21.11.2017 | Agilent Technologies Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
25.02.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
03.01.2019 | Agilent Technologies Buy | Needham & Company, LLC | |
21.11.2017 | Agilent Technologies Overweight | Barclays Capital | |
18.01.2017 | Agilent Technologies Buy | Deutsche Bank AG | |
04.01.2017 | Agilent Technologies Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
15.07.2019 | Agilent Technologies Equal Weight | Barclays Capital | |
30.05.2019 | Agilent Technologies Peer Perform | Wolfe Research | |
17.05.2016 | Agilent Technologies Equal Weight | Barclays Capital | |
07.01.2016 | Agilent Technologies Hold | Deutsche Bank AG | |
07.01.2016 | Agilent Technologies Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
06.02.2009 | Varian underweight | Barclays Capital | |
16.08.2005 | Agilent sell | Banc of America Sec. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Agilent Technologies Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen